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EDITORIAL
Heme oxygenase-1 in renal injury: Conclusions of studies in
humans and animal models
Heme, a ferroprotoporphyrin, derived from various demonstrated that cytoprotection against heme protein–
hemoproteins, is catabolized by the enzyme heme oxy- induced toxicity can occur even when HO-1 is induced
genase [1–4]. It degrades heme to biliverdin, which is by agents such as an endotoxin [10] or by the administra-
metabolized by biliverdin reductase to bilirubin. The ca- tion of heterologous antibody as in nephrotoxic serum
tabolism of heme to biliverdin by heme oxygenase re- nephritis [11]. More recently, they confirmed the role of
quires oxygen and the reduced form of nicotinamide- this enzyme in HO-1–deficient mice stressed with heme
adenine dinucleotide phosphate (NADPH). During this proteins. These mice exhibited severe renal insufficiency
reaction iron is released from the heme ring and carbon and increased mortality [12].
monoxide is produced. Heme oxygenase activity is con- Nath et al extended the above studies to explore
fined to its three isoenzymes: HO-1, HO-2, and HO-3. whether HO-1 protected against the inflammatory as-
HO-1 is the isoenzyme induced in tissues by various stim- sault by heme proteins in the HO-1–deficient mice in a
uli, a large number of which are pro-oxidant. During the clinical setting. The impetus for the studies described in
last decade, there has been a tremendous interest in the the accompanying article was a patient with paroxysmal
biology of HO-1, in part because it serves as a fortuitous nocturnal hemoglobinuria who developed progressive
protective agent as opposed to the deleterious effects ex- chronic tubulointerstitial disease with up-regulation of
erted by the degradation products of its substrate, heme, HO-1 in the kidney and in renal tubular cells exposed
in various forms of tissue injury [2, 3]. The mechanisms to patient’s urine. In previous studies in rats, Nath and
relevant to the protective effects of HO-1 in human renal colleagues had demonstrated a triphasic response in the
disease, reinforced in animal studies, are highlighted in kidney exposed to heme proteins. Initially, kidneys ex-
this issue of Kidney International by Nath et al [5]. hibit acute sensitivity to hemoproteins, followed by ac-
The studies described herein [5] represent a contin- quisition of resistance to them, and finally a progressive
uum of intense efforts launched in Dr. Nath’s laboratory tubulointerstitial disease with up-regulation of inflam-
a decade ago to delineate the mechanism(s) of renal matory and fibrogenic cytokines [13]. Based on this infor-
injury and responses to such injury in the kidney exposed mation, they explored the status of HO-1 in various
to heme proteins [5–13]. In 1992, he and his colleagues phases and devised a regimen that used sufficiently low
demonstrated that exposure to heme proteins produces doses of murine hemoglobin so that its repeated adminis-
a rapid increase in the expression of HO-1 and ferritin, tration caused minimal mortality in HO-1–deficient
and such an induction provides a protective response mice. An acute sensitivity was noted both in wild-type
to renal tubular injury [6]. These studies represent a and HO-1–deficient mice with the initial doses of hemo-
landmark contribution because they provide the first globin, and eventually both the strains developed resis-
demonstration—in any tissue and for any insult and in tance as well to heme proteins. Remarkably, the response
either in vitro or in vivo settings—for a protective role differed in the third phase. HO-1–deficient mice had
of HO-1, a role only previously theorized for this enzyme marked exacerbation of tubulointerstitial disease, sug-
[1]. Further strides were made to delineate the mecha- gesting that the capacity to recruit HO-1, as it occurs in
nism(s) by which induced HO-1 provided protection wild-type mice, provides a mechanism that holds in check
against the oxidant injury to the kidney. The authors the inflammatory response induced by heme proteins.
explored the mechanisms by which heme proteins in- To delineate the mechanism involved, they focused on
duced renal vasoconstriction [7, 8] and also identified the the monocyte chemoattractant peptide (MCP-1), since
renal intracellular targets vulnerable to the deleterious the latter contributes to progressive tubulointerstitial in-
effects of such toxic proteins [7, 9]. In addition, they jury [14] as a redox-sensitive gene. Novel data emerged
from the experiments. A relatively very high up-regula-
tion of MCP-1 in the kidney was observed in HO-defi-
Key words: nuclear factor-kB (NF-kB) heme proteins, tubulointersti-
cient mice with repeated chronic administration of hemo-tial injury, fibrogenic cytokines inflammatory response, monocyte
chemoattractant peptide (MCP-1). globin. Concomitantly, nuclear factor-kappa B (NF-kB),
a transcription factor that induces the expression ofÓ 2001 by the International Society of Nephrology
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MCP-1, was avidly activated in the HO-1–deficient mice. experimental observations, demonstrates how the explo-
This implied that HO-1 down-regulates MCP-1 by inhib- ration of a human disease process can provide important
iting the activation of NF-kB. These findings clearly dem- insights and engender important questions that can be
onstrate that the induction of HO-1 serves as an adaptive analyzed using genetically engineered mice.
response in the kidney subjected to repeated chronic
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